$1.47
0.010.68%
Last update: Nov 2, 12:15 AM
Century Therapeutics Inc
IPSCNASDAQ
Century Therapeutics (IPSC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.17 | $-0.29 | $-0.35 |
| Actual | $-0.17 | $-0.11 | $-0.25 | $-0.40 |
| Surprise | -41.7% | +35.3% | +13.8% | -14.3% |
| Revenue | ||||
| Estimate | — | — | $-62500 | $25000 |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | +100.0% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.11 | $-0.12 | $-0.13 | $-0.13 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.17 | $-0.12 | -41.7 % |
| Q1 | May 13, 2026 | $-0.11 | $-0.17 | 35.3 % |
| Q4 | Mar 12, 2026 | $-0.25 | $-0.29 | 13.8 % |
| Q3 | Nov 13, 2025 | $-0.40 | $-0.35 | -14.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Mar 12, 2026 | $0 | $-62.50K | 100.0 % |
| Q3 | Nov 13, 2025 | $0 | $25.00K | -100.0 % |
| Q1 | May 15, 2025 | $109.16M | $45.52M | 139.8 % |
| Q4 | Mar 19, 2025 | $4.17M | $975.00K | 328.0 % |
